Understanding what changes in the brain during depression
Originally from Brazil, Goya-Maldonado came to Germany in 2005 because he believed that he would have the best chances here of being able to study the correlations between psychiatric disorders and the underlying biological processes in the brain. Rather than returning to Brazil as planned after obtaining his PhD in Heidelberg, he decided to stay. “Germany has an expansive and nuanced medical research landscape that is unparalleled”, says Goya-Maldonado. He worked directly with patients for a time in Munich and is therefore familiar with their problems and needs, as well as with everyday clinical practice. “However, what I was then lacking was the scientific input that I am so passionate about. That’s why I went to Göttingen – back into research”, explains Goya-Maldonado.
He now coordinates the so-called PreNeSt project there within the framework of a junior research programme run by the Federal Ministry of Education and Research (BMBF): using a technique known as transcranial magnetic stimulation (TMS), the project aims to treat affective disorders such as depression more effectively. TMS involves using a magnetic coil to generate magnetic fields that are brought close to certain parts of the head so as to stimulate specific areas in the brain. Functional magnetic resonance imaging is used to identify those neural networks that are suitable for TMS and subsequently to observe the effect TMS has on them. “We attempt to locate the neural networks that play an important role in depression – and at the same time to stimulate them again”, explains Goya-Maldonado.
However, it is not always the same neural networks that are damaged in every patient. Different neural networks may be affected, and every individual disorder can cause a depression. “In other words, not all forms of depression are alike. Depending on which neural network is disrupted, we can provide individual and thus more targeted treatment”, says Goya-Maldonado. In the field of psychiatry, this kind of more targeted therapy that does not focus only on the symptoms would be a revolution.